ICD Valuation
| 040910 Stock | KRW 6,030 60.00 1.01% |
At this time, the entity appears to be undervalued. ICD Co retains a regular Real Value of W6376.95 per share. The prevalent price of the entity is W6030.0. Our model calculates the value of ICD Co from inspecting the entity fundamentals such as price to earning of 45.24 X, and Shares Outstanding of 16.45 B as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that ICD's price fluctuation is very steady at this time. Calculation of the real value of ICD Co is based on 3 months time horizon. Increasing ICD's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ICD is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ICD Stock. However, ICD's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6030.0 | Real 6376.95 | Hype 6030.0 | Naive 5759.63 |
The real value of ICD Stock, also known as its intrinsic value, is the underlying worth of ICD Co Company, which is reflected in its stock price. It is based on ICD's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ICD's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ICD Co helps investors to forecast how ICD stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ICD more accurately as focusing exclusively on ICD's fundamentals will not take into account other important factors: ICD Total Value Analysis
ICD Co is presently estimated to have takeover price of 244.19 B with market capitalization of 244.19 B, debt of 1.87 B, and cash on hands of 9.95 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ICD fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
244.19 B | 244.19 B | 1.87 B | 9.95 B |
ICD Investor Information
The book value of the company was presently reported as 5532.14. The company recorded earning per share (EPS) of 335.99. ICD Co had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from ICD's historical financial statements, ICD Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.ICD Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ICD has an asset utilization ratio of 56.24 percent. This suggests that the Company is making W0.56 for each dollar of assets. An increasing asset utilization means that ICD Co is more efficient with each dollar of assets it utilizes for everyday operations.ICD Profitability Analysis
The company reported the revenue of 72.06 B. Net Income was 5.41 B with profit before overhead, payroll, taxes, and interest of 12.46 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ICD's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ICD and how it compares across the competition.
About ICD Valuation
The stock valuation mechanism determines ICD's current worth on a weekly basis. Our valuation model uses a comparative analysis of ICD. We calculate exposure to ICD's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ICD's related companies.8 Steps to conduct ICD's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ICD's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ICD's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ICD's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ICD's revenue streams: Identify ICD's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ICD's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ICD's growth potential: Evaluate ICD's management, business model, and growth potential.
- Determine ICD's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ICD's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ICD Stock analysis
When running ICD's price analysis, check to measure ICD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICD is operating at the current time. Most of ICD's value examination focuses on studying past and present price action to predict the probability of ICD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICD's price. Additionally, you may evaluate how the addition of ICD to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |